Does EVEROLIMUS Cause Renal cancer? 130 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 130 reports of Renal cancer have been filed in association with EVEROLIMUS (EVEROLIMUS). This represents 0.3% of all adverse event reports for EVEROLIMUS.
130
Reports of Renal cancer with EVEROLIMUS
0.3%
of all EVEROLIMUS reports
34
Deaths
28
Hospitalizations
How Dangerous Is Renal cancer From EVEROLIMUS?
Of the 130 reports, 34 (26.2%) resulted in death, 28 (21.5%) required hospitalization, and 3 (2.3%) were considered life-threatening.
Is Renal cancer Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for EVEROLIMUS. However, 130 reports have been filed with the FAERS database.
What Other Side Effects Does EVEROLIMUS Cause?
Death (5,090)
Malignant neoplasm progression (3,789)
Diarrhoea (3,061)
Fatigue (2,946)
Stomatitis (2,692)
Nausea (2,079)
Dyspnoea (1,925)
Drug ineffective (1,837)
Pyrexia (1,664)
Decreased appetite (1,633)
What Other Drugs Cause Renal cancer?
RANITIDINE (40,791)
ADALIMUMAB (271)
ETANERCEPT (182)
SUNITINIB MALATE (174)
VALSARTAN (163)
PAZOPANIB (152)
AXITINIB (146)
OMEPRAZOLE (135)
ESOMEPRAZOLE (130)
LANSOPRAZOLE (125)
Which EVEROLIMUS Alternatives Have Lower Renal cancer Risk?
EVEROLIMUS vs EVOLOCUMAB
EVEROLIMUS vs EXELON
EVEROLIMUS vs EXEMESTANE
EVEROLIMUS vs EXENATIDE
EVEROLIMUS vs EXFORGE